Stifel Financial Corp cut its stake in Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 11.5% in the third quarter, Holdings Channel.com reports. The fund owned 12,641 shares of the company’s stock after selling 1,648 shares during the quarter. Stifel Financial Corp’s holdings in Addus HomeCare were worth $1,682,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently made changes to their positions in the company. UMB Bank n.a. increased its position in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares during the period. Quarry LP acquired a new position in shares of Addus HomeCare in the 3rd quarter valued at $28,000. Quest Partners LLC purchased a new stake in Addus HomeCare in the 2nd quarter valued at $31,000. Innealta Capital LLC acquired a new stake in Addus HomeCare during the 2nd quarter worth $44,000. Finally, Farther Finance Advisors LLC grew its position in Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.
Addus HomeCare Stock Performance
Addus HomeCare stock opened at $131.40 on Friday. The stock has a fifty day moving average of $125.84 and a two-hundred day moving average of $124.87. Addus HomeCare Co. has a fifty-two week low of $85.94 and a fifty-two week high of $136.12. The company has a market capitalization of $2.38 billion, a price-to-earnings ratio of 30.07, a PEG ratio of 2.11 and a beta of 1.01.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on ADUS shares. Oppenheimer increased their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. KeyCorp initiated coverage on Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price target for the company. Stephens increased their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Finally, JMP Securities initiated coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective on the stock. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $133.67.
Check Out Our Latest Stock Analysis on Addus HomeCare
Insider Activity
In other news, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares in the company, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- How Investors Can Find the Best Cheap Dividend Stocks
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Best Aerospace Stocks Investing
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Stock Dividend Cuts Happen Are You Ready?
- 2 Underrated Quantum Computing Companies Starting to Rally
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.